Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retina Australia is a prominent Australian non-profit organization dedicated to funding medical research into the causes, treatments, and potential cures for inherited retinal diseases (IRDs). Since its inception in 1983, the organization has committed millions of dollars to support world-class research projects focusing on gene therapy, stem cell technology, and molecular diagnostics. Retina Australia serves as a vital resource for the low-vision community, providing peer support, information services, and advocacy for patients with conditions such as Retinitis Pigmentosa and Stargardt disease. The organization operates as a member of Retina International, ensuring that Australian research is integrated into the global effort to eliminate blindness caused by retinal dystrophies. It also facilitates patient participation in clinical trials and maintains a registry to connect individuals with relevant research opportunities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retina Australia.